1. Home
  2. AOD vs SGP Comparison

AOD vs SGP Comparison

Compare AOD & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo abrdn Total Dynamic Dividend Fund of Beneficial Interest

AOD

abrdn Total Dynamic Dividend Fund of Beneficial Interest

HOLD

Current Price

$10.41

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$20.78

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AOD
SGP
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
932.9M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
AOD
SGP
Price
$10.41
$20.78
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.00
AVG Volume (30 Days)
367.2K
51.9K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.44
$20.15
52 Week High
$10.77
$30.56

Technical Indicators

Market Signals
Indicator
AOD
SGP
Relative Strength Index (RSI) 57.59 36.44
Support Level $9.82 N/A
Resistance Level $10.60 $26.29
Average True Range (ATR) 0.14 1.54
MACD -0.02 -0.28
Stochastic Oscillator 60.67 2.59

Price Performance

Historical Comparison
AOD
SGP

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: